MicroRNA-629 promotes the tumorigenesis of non-small-cell lung cancer by targeting FOXO1 and activating PI3K/AKT pathway.

CONCLUSIONS: MiR-629 promotes the progression of NSCLC by targeting FOXO1 and regulating EMT/PI3K/AKT pathway. PMID: 32716350 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32716350?dopt=Abstract

Source: Cancer Biomarkers - July 28, 2020 Category: Cancer & Oncology Tags: Cancer Biomark Source Type: research

More News: Cancer | Cancer & Oncology | Lung Cancer | Non-Small Cell Lung Cancer | Study